Lv4
460 积分 2025-04-06 加入
CLDN6-specific CAR-T cells plus amplifying RNA vaccine in relapsed or refractory solid tumors: the phase 1 BNT211-01 trial
26天前
已完结
Discovery of lung adenocarcinoma tumor antigens and ferroptosis subtypes for developing mRNA vaccines
26天前
已完结
Identifying novel tumor-related antigens and immune phenotypes for developing mRNA vaccines in lung adenocarcinoma
26天前
已完结
Identification of Tumor Antigens and Immune Subtypes in Lung Adenocarcinoma for mRNA Vaccine Development
26天前
已完结
Identification of Tumor Antigens and Immune Subtypes in Lung Adenocarcinoma for mRNA Vaccine Development
26天前
已完结
The Paradigm Shift in Treatment from Covid-19 to Oncology with mRNA Vaccines
26天前
已完结
Screening of novel tumor-associated antigens for lung adenocarcinoma mRNA vaccine development based on pyroptosis phenotype genes
26天前
已完结
Potential Immune Biomarker Candidates and Immune Subtypes of Lung Adenocarcinoma for Developing mRNA Vaccines
26天前
已完结
Characteristics of tumor microenvironment and novel immunotherapeutic strategies for non-small cell lung cancer
27天前
已完结
Targeting cancer with mRNA–lipid nanoparticles: key considerations and future prospects
28天前
已完结
皖公网安备34019202002308
